<DOC>
	<DOC>NCT01297257</DOC>
	<brief_summary>The primary objective of the DELIVER Study is to assess the deliverability of the Resolute Integrity Stent as primary stent or as a secondary cross-over stent following delivery failure of another stent type in real world patients.</brief_summary>
	<brief_title>DELIVER Study: DELiverability of the Resolute Integrity Stent in All-Comer Vessels and Cross-OvER Stenting</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Minimum legal age (18) Acceptable candidate for treatment with a drugeluting stent in accordance with applicable guidelines Patient has consented to participate and authorized in writing the collection and release of medical information Pregnancy Participating in another study that interferes with study endpoints Untreatable hypersensitivity or allergies to aspirin, heparin, clopidogrel, zotarolimus or similar drugs or contrast media Patients in whom antiplatelet and/or anticoagulation therapy is contraindicated</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>